CoRegen News and Activities

Acquisition, funding and merger involving CoRegen.

• CoRegen has just announced a $93 Million fundraising (posted on July 11 2025).

View the org chart displaying its 15 main executives

Most searched biographies at CoRegen

• Steve Gorlin, Vice Chairman and President
• Bert O'Malley, Director
• William Haseltine, Director

Popular executive movements at CoRegen

• Bert O'Malley has joined the company as Director  (posted on December 23 2025).

Create your alert
to follow the executive moves at CoRegen.

CoRegen has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by CoRegen

Social media about CoRegen

• CoRegen on Wikipedia, Google News & Yahoo Finance
• CoRegen on LinkedIn, X (Twitter) & YouTube